TÜBINGEN, Germany, December 28, 2017 – CureVac, a clinical-stage biopharma-ceutical company pioneering the field of mRNA-based technology, announced today that Ingmar Hoerr, Ph.D., co-founder and CEO of CureVac, will present at the J.P. Morgan 35th Annual Healthcare Conference 2017 to be held January 9-12, 2017, at the Westin St. Francis Hotel in San Francisco, CA.
Details of CureVac's presentation are as follows:
Event: J.P. Morgan 35th Annual Healthcare Conference 2017
Date: Wednesday, January 11, 2017
Time: 2:00 p.m. (Pacific Time)
Location: Westin St. Francis Hotel, San Francisco, CA